Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax

Lima, K., Vicari, H. P., Carlos, J. A. E. G., da Silva, J. C. L., Figueiredo-Pontes, L. L. de, Rego, E. M., & Machado-Neto, J. A. (2022, January 1). Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax. Hematology, Transfusion and Cell Therapy. Elsevier Editora Ltda. https://doi.org/10.1016/j.htct.2021.01.004